| Company Name: | AMN Healthcare Services, Inc. | | Ticker Symbol: | AHS | | | WWW Address: | www.amnhealthcare.com |
| CEO: | Ms. Susan R. Nowakowski | | No. of Employees: | 1,840 |
| Common Issue Type: | CS | | Business Description: | AMN Healthcare Services, Inc. is a healthcare staffing company which recruit and place physicians, nurses and allied health professionals nationally and internationally on a temporary or permanent basis at healthcare facilities throughout the US.
|
| | | Industry Information: | DIVERSIFIED SERVICES - Staffing & Outsourcing Services [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 14.22 |  0.24 | - | - | 14.09 | 14.27 | 13.95 | 195239 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 654.7 | 46.0 | 1.66 | 0.37 | 0.00 | 38.4 | 0.0 | 15.94 - 5.45 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 14.22 | $ | | PE Ratio - LTM | 38.4 | |
| Market Capitalisation | 654.7 | mil |
| Latest Shares Outstanding | 46.0 | mil |
| Earnings pS (EPS) | 0.37 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | | % |
| Revenue per Employee | 561,148 | $ |
| Effective Tax Rate | 40.3 | % |
| Float | 38.7 | mil |
| Float as % of Shares Outstanding | 84.4 | % |
| Foreign Sales | | mil |
| Domestic Sales | | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 21.30 | % |
| Research & Devlopment (R&D) as % of Revenue | 0.00 | % |
| Gross Profit Margin | 28.3 | % |
| EBITDA Margin | 7.1 | % |
| Pre-Tax Profit Margin | 2.9 | % |
| Assets Turnover | 1.8 | % |
| Return on Assets (ROA) | 3.3 | % |
| Return on Equity (ROE) | 9.4 | % |
| Return on Capital Invested (ROCI) | 5.0 | % |
| Current Ratio | 1.9 | |
| Leverage Ratio (Assets/Equity) | 2.8 | |
| Interest Cover | 2.1 | |
| Total Debt/Equity (Gearing Ratio) | 0.87 | |
| LT Debt/Total Capital | 46.0 | % |
| Working Capital pS | 2.05 | $ |
| Cash pS | 0.12 | $ |
| Book-Value pS | 3.96 | $ |
| Tangible Book-Value pS | -1.70 | $ |
| Cash Flow pS | 0.68 | $ |
| Free Cash Flow pS | 1.20 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 3.59 | |
| Price/Tangible Book Ratio | -8.38 | |
| Price/Cash Flow | 20.9 | |
| Price/Free Cash Flow | 11.9 | |
| P/E as % of Industry Group | 106.0 | % |
| P/E as % of Sector Segment | 137.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 1.2 | 99 | 2,038 | 9,219 |
| 4 Weeks | 14.45 | 12.29 | 13.77 | 3.3 | 96 | 3,424 | 68,488 |
| 13 Weeks | 15.94 | 10.34 | 12.76 | 11.4 | 102 | 3,984 | 251,022 |
| 26 Weeks | 15.94 | 10.27 | 10.40 | 36.7 | 112 | 3,122 | 387,179 |
| 52 Weeks | 15.94 | 5.45 | 5.92 | 140.2 | 187 | 2,713 | 675,513 |
| YTD | 15.94 | 10.34 | - | 23.1 | 105 | 3,442 | 326,980 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 14.11 | 13.98 | 14.42 | 12.65 | 11.45 | 1.66 | 1.97 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | -5.66 | 23.2 | 9.81 |
| Income | 0.00 | 0.0 | 0.00 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | -26.31 | NA | 6.58 |
| R&D | 0.00 | NA | 0.00 |
| Normalized Inc. | 0.00 | NA | 0.00 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | 7.5 | 36.8 | 7.5 |
| Earnings % | 0.0 | 0.0 | 0.0 |
| EPS % | 0.0 | 400.0 | 0.0 |
| EPS $ | 0.94 | 0.12 | 0.94 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 18.21 |
| Current Ratio | 1.9 |
| Quick Ratio (Acid Test) | 1.5 |
| Liquidity Ratio (Cash) | 0.05 |
| Receivables Turnover | 5.7 |
| Average Collection Period | 63 |
| Working Capital/Equity | 51.7 |
| Working Capital pS | 2.06 |
| Cash-Flow pS | 0.68 |
| Free Cash-Flow pS | 1.20 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 3.57 |
| Financial Leverage Ratio (Assets/Equity) | 2.8 |
| Debt Ratio | 64.8 |
| Total Debt/Equity (Gearing Ratio) | 0.87 |
| LT Debt/Equity | 0.87 |
| LT Debt/Capital Invested | 66.3 |
| LT Debt/Total Liabilities | 47.2 |
| Interest Cover | 2.1 |
| Interest/Capital Invested | 6.38 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 161.57 |
| Tobin's Q Ratio | 1.27 |
| Current P/E Ratio - LTM | 38.40 |
| Enterprise Value (EV)/EBITDA | 14.58 |
| Enterprise Value (EV)/Free Cash Flow | 29.12 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | -8.38 |
| Price/Book Ratio - LTM | 3.59 |
| Price/Cash Flow Ratio | 20.9 |
| Price/Free Cash Flow Ratio - LTM | 11.9 |
| Price/Sales Ratio | 0.69 |
| P/E Ratio (1 month ago) - LTM | 37.1 |
| P/E Ratio (26 weeks ago) - LTM | 0.0 |
| P/E Ratio (52 weeks ago) - LTM | 0.0 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | |
| P/E as % of Industry Group | 106.0 |
| P/E as % of Sector Segment | 137.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 40.6 |
| PER SHARE FIGURES |
| LT Debt pS | 3.46 |
| Current Liabilities pS | 2.40 |
| Tangible Book Value pS - LTM | -1.70 |
| Book Value pS - LTM | 3.96 |
| Capital Invested pS | 7.39 |
| Cash pS - LTM | 0.12 |
| Cash Flow pS - LTM | 0.68 |
| Free Cash Flow pS - LTM | 1.20 |
| Earnings pS (EPS) | 0.37 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | 5.77 |
| Free Cash Flow Margin 5YEAR AVG | 4.40 |
| Net Profit Margin | 1.8 |
| Net Profit Margin - 5YEAR AVRG. | 0.6 |
| Equity Productivity | 5.24 |
| Return on Equity (ROE) | 9.4 |
| Return on Equity (ROE) - 5YEAR AVRG. | 2.7 |
| Capital Invested Productivity | 2.80 |
| Return on Capital Invested (ROCI) | 5.0 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 1.5 |
| Assets Productivity | 1.80 |
| Return on Assets (ROA) | 3.3 |
| Return on Assets (ROA) - 5YEAR AVRG. | 1.0 |
| Gross Profit Margin | 28.3 |
| Gross Profit Margin - 5YEAR AVRG. | 27.3 |
| EBITDA Margin - LTM | 7.1 |
| EBIT Margin - LTM | 5.6 |
| Pre-Tax Profit Margin | 2.9 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | -2.8 |
| Effective Tax Rate | 40.3 |
| Effective Tax Rate - 5YEAR AVRG. | 38.2 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 61 |
| Revenue per Employee | 561,148 |
| Net Income per Employee | 10,080 |
| Average Collection Period | 61 |
| Receivables Turnover | 5.7 |
| Day's Inventory Turnover Ratio | |
| Inventory Turnover | 0.0 |
| Inventory/Sales | 0.0 |
| Accounts Payble/Sales | 5.52 |
| Assets/Revenue | 0.56 |
| Net Working Capital Turnover | 10.12 |
| Fixed Assets Turnover | 3.04 |
| Total Assets Turnover | 1.8 |
| Revenue per $ Cash | 167.92 |
| Revenue per $ Plant | 64.39 |
| Revenue per $ Common Equity | 5.24 |
| Revenue per $ Capital Invested | 2.80 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 21.3 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 21.2 |
| Research & Devlopment (R&D) as % of Revenue | 0.0 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 0.0 |
|
|  
|
| |
 |  |
